Table 1 Clinical characteristics of 544 patients with UCEC from TCGA database
From: A novel risk score system of immune genes associated with prognosis in endometrial cancer
Clinicopathological characteristics | Number (total = 544) (%) | |
|---|---|---|
Age at diagnosis | 31–90 years (median: 64 years) | |
Race | Â | |
 White | 372 | 72.37% |
 Black or African American | 109 | 21.21% |
 Other | 33 | 6.42% |
Menopause status | Â | |
 Pre | 52 | 10.46% |
 Post | 445 | 89.54% |
Surgical approach | Â | |
 Minimally invasive | 203 | 38.96% |
 Open | 318 | 61.04% |
Histological type | Â | |
 Serous endometrial adenocarcinoma | 115 | 21.14% |
 Endometrioid endometrial adenocarcinoma | 407 | 74.82% |
 Mixed serous and endometrioid | 22 | 4.04% |
Grade | Â | |
 Low/moderate (G1/G2) | 221 | 40.63% |
 High (G3) | 323 | 59.38% |
Tumor invasion depth | Â | |
 < 1/2 | 254 | 55.70% |
 ≥ 1/2 | 202 | 44.30% |
Tumor status | Â | |
 Tumor free | 428 | 84.42% |
 With tumor | 79 | 15.58% |
Residual tumor | Â | |
 No residual (R0) | 375 | 90.80% |
 With residual (R1/R2) | 38 | 9.20% |
Peritoneal washing | Â | |
 Negative | 352 | 85.85% |
 Positive | 58 | 14.15% |
Pelvic lymph node | Â | |
 Negative | 368 | 83.26% |
 Positive | 74 | 16.74% |
Para-aortic lymph node | Â | |
 Negative | 331 | 89.70% |
 Positive | 38 | 10.30% |
Stage | Â | |
 I | 339 | 62.32% |
 II | 52 | 9.56% |
 III | 123 | 22.61% |
 IV | 30 | 5.51% |